Dakota Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.2M Sell
41,150
-1,348
-3% -$178K 0.1% 186
2026
Q1
$5.92M Sell
42,498
-300
-0.7% -$42K 0.13% 156
2025
Q4
$5.25M Sell
42,798
-159
-0.4% -$19.3K 0.09% 165
2025
Q3
$4.77M Sell
42,957
-1,522
-3% -$173K 0.1% 160
2025
Q2
$4.93M Buy
44,479
+37
+0.1% +$3.94K 0.1% 161
2025
Q1
$4.98M Sell
44,442
-571
-1% -$58.9K 0.12% 154
2024
Q4
$4.16M Buy
45,013
+108
+0.2% +$9.72K 0.1% 171
2024
Q3
$3.76M Sell
44,905
-123
-0.3% -$9.38K 0.09% 202
2024
Q2
$3.09M Buy
45,028
+6,335
+16% +$423K 0.07% 219
2024
Q1
$2.83M Sell
38,693
-1,518
-4% -$117K 0.07% 225
2023
Q4
$3.26M Sell
40,211
-2,039
-5% -$159K 0.13% 159
2023
Q3
$3.17M Buy
42,250
+289
+0.7% +$22.2K 0.14% 154
2023
Q2
$3.23M Buy
41,961
+38,153
+1,002% +$3.04M 0.15% 132
2023
Q1
$316K Buy
3,808
+695
+22% +$57.6K 0.02% 458
2022
Q4
$267K Buy
+3,113
New +$247K 0.02% 468
2022
Q3
Sell
-4,657
Closed -$287K 587
2022
Q2
$287K Buy
+4,657
New +$288K 0.03% 381

Other funds holding GILD

Dakota Wealth Management's GILD Position: Q2 2026 in Review

Dakota Wealth Management reduced its Gilead Sciences (GILD) stake by 3.2% in Q2 2026, selling an estimated $178K and leaving 41,150 shares worth $5.2M. The position accounts for 0.1% of the portfolio, ranked #186.

Dakota Wealth Management first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dakota Wealth Management held 41,150 shares of Gilead Sciences worth $5.2M as of Q2 2026.
  • Dakota Wealth Management sold 1,348 Gilead Sciences shares in Q2 2026, an estimated $178K.
  • Gilead Sciences made up 0.1% of Dakota Wealth Management's portfolio in Q2 2026, its #186 holding.
  • Dakota Wealth Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • Dakota Wealth Management's Gilead Sciences position peaked at $5.92M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.